Gossamer Bio Inc (GOSS)
0.42
+0.00%
Gossamer Bio Inc (GOSS) is currently trading at $0.42. This represents a gain of 0% from the previous session. With a market capitalization of $0.10B, GOSS is a key component of the Health Care sector. Investors looking to trade GOSS should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade GOSS commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Gossamer Bio Inc (GOSS) shows a bullish trend. Analysts are watching the 0.00 level closely.
Fundamentals
Mkt Cap0.10B
P/E Ratio0.0000
Volume815,391
60-Day Technical Chart
Advanced Charting
Need more indicators for GOSS? Use the world's #1 platform.
Open GOSS on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $0
| Metric |
GOSS +0.00% |
OPTT +0.00% |
AGL +0.00% |
ANEB -0.39% |
|---|---|---|---|---|
| Price | $0.42 | $0.42 | $0.39 | $0.43 |
| Mkt Cap | $0.10B | $0.08B | $0.16B | $0.02B |
| - | View → | View → | View → |
Latest Headlines
Gossamer Bio shares plummet as lung disease drug fails late-stage trial
Reuters • Feb 23, 2026
Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension
Business Wire • Feb 23, 2026
Gossamer Bio stock tumbles 80% on trial miss
Investing.com • Feb 23, 2026
Gossamer Bio (GOSS) Downgraded by Wedbush with Significant PT Re
GuruFocus • Feb 24, 2026
A Look At Gossamer Bio (GOSS) Valuation After Barclays Strong Buy Upgrade And Rising Institutional Ownership
Yahoo Finance • Feb 16, 2026
● Gemini Agentic AI Analyst Insight for GOSS
Market Education
- How can Retail Traders not lose money to Institutional Traders Jul 15, 2023
- How to trade 0DTE $SPY options Sep 27, 2025
- What do these rich Traders do - Peek into their day Jul 15, 2023
External Research